Some cardiac effects of 1-allyl-2-benzyl-piperidine hc1, in vitro and in vivo.
D000475:Alkenes / Q000494:pharmacology*; D000498:Allyl Compounds / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001001:Anura; D001593:Benzyl Compounds / Q000494:pharmacology*; D002122:Calcium Chloride / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004336:Drug Antagonism; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D007928:Lethal Dose 50; D008012:Lidocaine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010042:Ouabain / Q000037:antagonists & inhibitors; D010880:Piperidines / Q000494:pharmacology*; D012584:Sciatic Nerve; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control
D000475:Alkenes; D000498:Allyl Compounds; D000889:Anti-Arrhythmia Agents; D001593:Benzyl Compounds; D010880:Piperidines; D010042:Ouabain; D008012:Lidocaine; D007545:Isoproterenol; D002122:Calcium Chloride; D009638:Norepinephrine